Published in J Nucl Med on September 01, 1995
SIRT3 opposes reprogramming of cancer cell metabolism through HIF1α destabilization. Cancer Cell (2011) 3.71
Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study. Eur J Nucl Med Mol Imaging (2008) 1.54
18F-FDG uptake in lung, breast, and colon cancers: molecular biology correlates and disease characterization. J Nucl Med (2009) 1.52
Characterization and performance of a near-infrared 2-deoxyglucose optical imaging agent for mouse cancer models. Anal Biochem (2008) 1.31
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer. Eur J Nucl Med Mol Imaging (2006) 1.27
Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET. Nat Rev Urol (2009) 1.24
Molecular imaging of hypoxia with radiolabelled agents. Eur J Nucl Med Mol Imaging (2009) 1.23
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography. Breast Cancer Res (2005) 1.16
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging (2008) 1.07
Imaging evaluation of prostate cancer with 18F-fluorodeoxyglucose PET/CT: utility and limitations. Eur J Nucl Med Mol Imaging (2013) 1.05
Hypoxia in microscopic tumors. Cancer Lett (2008) 1.04
FDG uptake, a surrogate of tumour hypoxia? Eur J Nucl Med Mol Imaging (2008) 1.03
Biological characterisation of breast cancer by means of PET. Eur J Nucl Med Mol Imaging (2004) 1.02
Clinical biomarkers of angiogenesis inhibition. Cancer Metastasis Rev (2008) 0.98
Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy. Eur J Nucl Med Mol Imaging (2012) 0.97
Predictive and prognostic value of FDG-PET. Cancer Imaging (2008) 0.96
High 18F-FDG uptake in microscopic peritoneal tumors requires physiologic hypoxia. J Nucl Med (2010) 0.93
F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy. Semin Nucl Med (2015) 0.93
Glucose transporter-1 in pulmonary neuroendocrine carcinomas: expression and survival analysis. Mod Pathol (2009) 0.92
¹⁸F-FDG PET-CT during chemo-radiotherapy in patients with non-small cell lung cancer: the early metabolic response correlates with the delivered radiation dose. Radiat Oncol (2012) 0.91
PET radiopharmaceuticals for imaging of tumor hypoxia: a review of the evidence. Am J Nucl Med Mol Imaging (2014) 0.91
PET and PET/CT imaging of skeletal metastases. Cancer Imaging (2010) 0.88
Reproducibility of functional volume and activity concentration in 18F-FDG PET/CT of liver metastases in colorectal cancer. Eur J Nucl Med Mol Imaging (2012) 0.87
Dose escalation to high-risk sub-volumes based on non-invasive imaging of hypoxia and glycolytic activity in canine solid tumors: a feasibility study. Radiat Oncol (2013) 0.86
Viability and proliferation potential of adipose-derived stem cells following labeling with a positron-emitting radiotracer. Eur J Nucl Med Mol Imaging (2011) 0.85
Dose painting based on tumor uptake of Cu-ATSM and FDG: a comparative study. Radiat Oncol (2014) 0.85
The Glycolytic Phenotype is Correlated with Aggressiveness and Poor Prognosis in Invasive Ductal Carcinomas. J Breast Cancer (2012) 0.83
Clinicopathologic significance of GLUT1 expression and its correlation with Apaf-1 in colorectal adenocarcinomas. World J Gastroenterol (2011) 0.82
Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines? Eur J Nucl Med Mol Imaging (2011) 0.82
Prognostic value of tumour blood flow, [¹⁸F]EF5 and [¹⁸F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy. Eur J Nucl Med Mol Imaging (2014) 0.82
(18)F-FDG PET/CT for Diagnosis of Osteosclerotic and Osteolytic Vertebral Metastatic Lesions: Comparison with Bone Scintigraphy. Asian Spine J (2013) 0.81
Comparison of cell proliferation, protein, and glucose metabolism in musculoskeletal tumors in a PET study. J Biomed Biotechnol (2011) 0.81
(18)F-fluorodeoxyglucose uptake and tumor hypoxia: revisit (18)f-fluorodeoxyglucose in oncology application. Transl Oncol (2014) 0.80
Focal dose escalation using FDG-PET-guided intensity-modulated radiation therapy boost for postoperative local recurrent rectal cancer: a planning study with comparison of DVH and NTCP. BMC Cancer (2010) 0.79
The influence of tumor oxygenation on (18)F-FDG (fluorine-18 deoxyglucose) uptake: a mouse study using positron emission tomography (PET). Radiat Oncol (2006) 0.78
Uptake of [(18)F]EF5 as a Tracer for Hypoxic and Aggressive Phenotype in Experimental Head and Neck Squamous Cell Carcinoma. Transl Oncol (2014) 0.78
Expression of glycolysis-related proteins in solid papillary carcinoma of the breast according to basement membrane status. Yonsei Med J (2014) 0.77
MRI of High-Glucose Metabolism Tumors: a Study in Cells and Mice with 2-DG-Modified Superparamagnetic Iron Oxide Nanoparticles. Mol Imaging Biol (2016) 0.76
Evaluation of the association between HIF-1α and HER-2 expression, hormone receptor status, Ki-67 expression, histology and tumor FDG uptake in breast cancer. Oncol Lett (2016) 0.75
Incidental detection of prostate-specific antigen-negative metastatic prostate cancer initially presented with solitary pulmonary nodule on fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med (2015) 0.75
Associations between the standardized uptake value of (18)F-FDG PET/CT and demographic, clinical, pathological, radiological factors in lung cancer. Int J Clin Exp Med (2015) 0.75
Micro Regional Heterogeneity of 64Cu-ATSM and 18F-FDG Uptake in Canine Soft Tissue Sarcomas: Relation to Cell Proliferation, Hypoxia and Glycolysis. PLoS One (2015) 0.75
Expression of glucose transporter-1 is correlated with hypoxia-inducible factor 1α and malignant potential in pancreatic neuroendocrine tumors. Oncol Lett (2016) 0.75
The predictive value of (18)F-FDG PET-CT for assessing the clinical outcomes in locally advanced NSCLC patients after a new induction treatment: low-dose fractionated radiotherapy with concurrent chemotherapy. Radiat Oncol (2017) 0.75
Immunohistochemical differentiation between type B3 thymomas and thymic squamous cell carcinomas. Int J Clin Exp Pathol (2015) 0.75
A radiobiological model of radiotherapy response and its correlation with prognostic imaging variables. Phys Med Biol (2017) 0.75
Revisit 18F-fluorodeoxyglucose oncology positron emission tomography: "systems molecular imaging" of glucose metabolism. Oncotarget (2017) 0.75
Structure of yeast phenylalanine tRNA at 3 A resolution. Nature (1974) 10.27
New rapid gel sequencing method for RNA. Nature (1977) 9.56
Structure of nucleosome core particles of chromatin. Nature (1977) 6.24
The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett (1985) 4.73
Structure of yeast phenylalanine transfer RNA at 2.5 A resolution. Proc Natl Acad Sci U S A (1975) 4.57
The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragments. EMBO J (1993) 4.11
Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants. Radiographics (1999) 4.07
Outcomes of stroke patients in Medicare fee for service and managed care. JAMA (1997) 3.91
A crystallographic study of metal-binding to yeast phenylalanine transfer RNA. J Mol Biol (1977) 3.71
Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology (1993) 3.18
Demonstration of accuracy and clinical versatility of mutual information for automatic multimodality image fusion using affine and thin-plate spline warped geometric deformations. Med Image Anal (1997) 3.10
Estimating hospital costs. A multiple-output analysis. J Health Econ (1986) 3.09
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Current methods of transfer of young people with Type 1 diabetes to adult services. Diabet Med (2002) 2.76
Further refinement of the structure of yeast tRNAPhe. J Mol Biol (1978) 2.71
Pivotal study of iodine I 131 tositumomab for chemotherapy-refractory low-grade or transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2001) 2.71
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Degradation of collagen by a human granulocyte collagenolytic system. J Clin Invest (1968) 2.62
The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61
Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) (2001) 2.41
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer (1993) 2.26
Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA. Biochemistry (1985) 2.22
Does FDG uptake measure proliferative activity of human cancer cells? In vitro comparison with DNA flow cytometry and tritiated thymidine uptake. J Nucl Med (1993) 2.19
Lung cancer: reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology (1995) 2.11
Alfentanil for conscious sedation during colonoscopy. South Med J (1995) 2.07
Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04
A model for the tertiary structure of the 28 residue DNA-binding motif ('zinc finger') common to many eukaryotic transcriptional regulatory proteins. Protein Eng (1988) 1.98
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study. J Clin Endocrinol Metab (2005) 1.98
Atomic co-ordinates for yeast phenylalanine tRNA. Nucleic Acids Res (1975) 1.98
Pb(II)-catalysed cleavage of the sugar-phosphate backbone of yeast tRNAPhe--implications for lead toxicity and self-splicing RNA. Nature (1983) 1.92
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med (1999) 1.88
Metastases from non-small cell lung cancer: mediastinal staging in the 1990s--meta-analytic comparison of PET and CT. Radiology (1999) 1.88
X-ray diffraction study of a new crystal form of the nucleosome core showing higher resolution. J Mol Biol (1981) 1.81
Reevaluation of the standardized uptake value for FDG: variations with body weight and methods for correction. Radiology (1999) 1.78
Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose. Radiology (1996) 1.72
Iodine-131-anti-B1 radioimmunotherapy for B-cell lymphoma. J Clin Oncol (1996) 1.70
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant (2007) 1.70
Human granulocyte collagenase. Science (1968) 1.68
Differing roles for zinc fingers in DNA recognition: structure of a six-finger transcription factor IIIA complex. Proc Natl Acad Sci U S A (1998) 1.67
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
The home health visit: an appropriate unit for Medicare payment? Health Aff (Millwood) (1996) 1.67
Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J Sci Am (2006) 1.64
In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med (1993) 1.63
Multicenter phase II study of iodine-131 tositumomab for chemotherapy-relapsed/refractory low-grade and transformed low-grade B-cell non-Hodgkin's lymphomas. J Clin Oncol (2000) 1.63
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab (2014) 1.63
Fatal Clostridium difficile enteritis after total abdominal colectomy. J Clin Gastroenterol (1996) 1.63
Kallmann syndrome: MR findings. AJNR Am J Neuroradiol (1993) 1.60
Fingers and helices. Nature (1987) 1.59
Correlation between three-dimensional structure and chemical reactivity of transfer RNA. Nucleic Acids Res (1974) 1.58
Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) (1991) 1.56
Evaluation of the early effect of local irradiation on normal rodent bone marrow metabolism using FDG: preclinical PET studies. J Nucl Med (2000) 1.51
Iodine-125-MIBG to treat neuroblastoma: preliminary report. J Nucl Med (1990) 1.48
More on the contraindications to vasoconstrictors in dentistry. Oral Surg Oral Med Oral Pathol (1993) 1.46
Tumor-absorbed-dose estimates versus response in tositumomab therapy of previously untreated patients with follicular non-Hodgkin's lymphoma: preliminary report. Cancer Biother Radiopharm (2000) 1.46
The need for better methods to determine release criteria for patients administered radioactive material. Health Phys (1998) 1.44
Bone marrow cell trafficking following intravenous administration. Br J Haematol (1999) 1.43
Hypothermic machine preservation in human liver transplantation: the first clinical series. Am J Transplant (2009) 1.42
Intratumoral distribution of tritiated fluorodeoxyglucose in breast carcinoma: I. Are inflammatory cells important? J Nucl Med (1995) 1.42
Glucose transporters and FDG uptake in untreated primary human non-small cell lung cancer. J Nucl Med (1999) 1.41
Untreated lung cancer: quantification of systematic distortion of tumor size and shape on non-attenuation-corrected 2-[fluorine-18]fluoro-2-deoxy-D-glucose PET scans. Radiology (1996) 1.41
Workers' compensation introduction for physicians. Va Med Q (1995) 1.40
The future of dentistry. Dent Today (2001) 1.40
Symptomatic non-insulin-dependent diabetes mellitus during therapy with recombinant human growth hormone. J Pediatr (1993) 1.38
Radionuclide imaging metabolic activity of brown adipose tissue in a patient with pheochromocytoma. Exp Clin Endocrinol Diabetes (2004) 1.37
Purification and crystallization of the EcoRV restriction endonuclease. J Biol Chem (1985) 1.37
Germ cell tumor: differentiation of viable tumor, mature teratoma, and necrotic tissue with FDG PET and kinetic modeling. Radiology (1999) 1.36
Use of extreme position changes in acute respiratory failure. Crit Care Med (1976) 1.31
House staff attitudes toward teaching. J Med Educ (1970) 1.30
Uptake of 2-deoxy-2-[18F]fluoro-D-glucose in the normal testis: retrospective PET study and animal experiment. Ann Nucl Med (1997) 1.29
Cardiovascular function in shock. Responses to volume loading and isoproterenol infusion. Circulation (1967) 1.26
Why do so few HMOs offer Medicare risk plans in rural areas? Health Care Financ Rev (1995) 1.26
Improved radioimaging and tumor localization with monoclonal F(ab')2. J Nucl Med (1983) 1.26
Do preset per visit payment rates affect home health agency behavior? Health Care Financ Rev (1994) 1.25
Preliminary assessment of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with bladder cancer. Eur J Nucl Med (1997) 1.24
Role of renal prostaglandins during antidiuresis and water diuresis in man. Kidney Int (1982) 1.24
Do school-based health centers improve adolescents' access to health care, health status, and risk-taking behavior? J Adolesc Health (1996) 1.22
Access and outcomes of elderly patients enrolled in managed care. JAMA (1994) 1.22
Xenopus transcription factor IIIA binds primarily at junctions between double helical stems and internal loops in oocyte 5S RNA. EMBO J (1987) 1.20
Conservation of the molecular structure of yeast phenylalanine transfer RNA in two crystal forms. Proc Natl Acad Sci U S A (1974) 1.20
Rapid detection of human infections with fluorine-18 fluorodeoxyglucose and positron emission tomography: preliminary results. Eur J Nucl Med (1998) 1.19
Comparison of netilmicin with gentamicin in the therapy of experimental Escherichia coli meningitis. Antimicrob Agents Chemother (1978) 1.18
Adsorption complex of filamentous fd virus. J Mol Biol (1981) 1.18
Adrenergic modulation of extrarenal potassium disposal. N Engl J Med (1980) 1.17
Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol (1998) 1.17
An outbreak of adenovirus type 7 infection in children in Montreal. Can Med Assoc J (1973) 1.16
Intratumoral distribution of tritiated-FDG in breast carcinoma: correlation between Glut-1 expression and FDG uptake. J Nucl Med (1996) 1.15
In vitro comparison of cell proliferation kinetics and uptake of tritiated fluorodeoxyglucose and L-methionine in squamous-cell carcinoma of the head and neck. J Nucl Med (1995) 1.14
Comparison of hemodynamic responses to whole blood and plasma expanders in clinical traumatic shock. Surg Gynecol Obstet (1965) 1.13
42S p48--the most abundant protein in previtellogenic Xenopus oocytes--resembles elongation factor 1 alpha structurally and functionally. EMBO J (1987) 1.13
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study. Aliment Pharmacol Ther (2011) 1.12
Pf1 filamentous bacterial virus. X-ray fibre diffraction analysis of two heavy-atom derivatives. J Mol Biol (1981) 1.10
Study of chloroquine toxicity and a drug-induced cerebrospinal lipodystrophy in swine. Am J Pathol (1968) 1.10
Primary structure and genetic organization of phage T4 DNA ligase. Nucleic Acids Res (1983) 1.10